What does 12 months of tirzepatide cost?
As of November 20, 2026, twelve months of compounded tirzepatide cost from $1,027 (Collective, including its $199 yearly membership) to $5,187 (Remedy Meds, 13 four-week cycles) at programs that print a comparable price. NexLife costs $1,548 month to month or $1,380 on its 12-month plan paid upfront; brand Zepbound costs about $5,637.
Released · Last reviewed · how we verify
Compounded tirzepatide prices, November 20, 2026
| Program | Month to month, all-in | Billing basis | Year at that price | Lowest printed rate | Dose pricing | Read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | per month | $1,027 | $85.58 ($69 a month plus $199 a year) | same at every dose | 2026-11-20 |
| Mondae | $126 | per month | $1,512 | $114 (6-month plan, $684) | same at every dose | 2026-11-20 |
| NexLife | $129 | per month | $1,548 | $115 (12-month plan) | same at every dose | 2026-11-20 |
| Eden | $129 | per month | $1,548 | $129 (every month) | same at every dose | 2026-11-20 |
| Yucca Health | $139 | per month | $1,668 | $119 (12-month plan, $1,428 upfront) | same at every dose | 2026-11-20 |
| Fifty 410 | $199 | per 28-day cycle | $2,587 | $149.50 (8-week program at $299, not in all states) | not stated as flat | 2026-11-20 |
| Emerge Weight Loss | $269 | per 28-day cycle | $3,497 | $224 (2.5 mg, per 4 weeks) | not stated as flat | 2026-11-20 |
| OrderlyMeds | $299 | per month | $3,588 | $149 (2-month new-customer offer, $299) | same at every dose | 2026-11-20 |
| Noom Med | $299 | per 28-day cycle | $3,887 | $299 (per 4 weeks, billed $897 every 12 weeks) | not stated as flat | 2026-11-20 |
| Enhance.MD | $329 | per 28-day cycle | $4,277 | $280 (billed every 48 weeks) | not stated as flat | 2026-11-20 |
| Found | $339 | per 28-day cycle | $4,407 | $199 (12-month term, per 28-day cycle) | not stated as flat | 2026-11-20 |
| Remedy Meds | $399 | per 28-day cycle | $5,187 | $399 (4-week supply; $279 first month only) | same at every dose | 2026-11-20 |
Printed plan prices
| Program | Drug | Plan prices | Plan total or basis |
|---|---|---|---|
| NexLife | tirzepatide | $129 month to month; $125 / $119 / $115 a month on 3-, 6-, 12-month plans | $1,380 for 12 months, paid upfront |
| NexLife | semaglutide | $109 month to month; $105 / $99 / $95 on 3-, 6-, 12-month plans | $1,140 for 12 months, paid upfront |
| Yucca Health | tirzepatide | $139 month to month; $125 on 6 months; $119 on 12 months | $1,428 for 12 months, upfront |
| Yucca Health | semaglutide | $89 month to month; $75 on 6 months; $69 on 12 months | $828 for 12 months, upfront |
| Mondae | tirzepatide | $126 month to month; $124 on 3 months; $114 on 6 months | $684 for 6 months |
| Mondae | semaglutide | $87 month to month; $75 on 3 months; $69 on 6 months | $414 for 6 months |
| Found | tirzepatide | $339 per 28-day cycle month to month; $269 / $249 / $199 on 3-, 6-, 12-month terms | per 28-day cycle |
| Henry Meds | semaglutide | $297 a month; $1,782 for 6 months ($1,482 paid in full); $3,564 for 12 ($2,364 paid in full) | legal price page dated December 3, 2025 |
Limitations of this answer
Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy. This page reports prices and terms; whether any GLP-1 suits you is a decision for you and a licensed clinician.
Frequently asked
What does 12 months of tirzepatide cost?
As of November 20, 2026, twelve months of compounded tirzepatide cost from $1,027 (Collective, including its $199 yearly membership) to $5,187 (Remedy Meds, 13 four-week cycles) at programs that print a comparable price. NexLife costs $1,548 month to month or $1,380 on its 12-month plan paid upfront; brand Zepbound costs about $5,637.
How current are the prices on TopGLP1Providers?
Every price on TopGLP1Providers carries the date it was read on the program’s own page; the whole dataset was re-read on November 20, 2026, from 2026-11-21 00:33 to 00:57 UTC, and NexLife’s plan pages were checked again for this site on November 21 (UTC). Programs whose pages refused automated reads that day, such as TrimRx, MEDVi, bmiMD, Embody, Ro and Hims & Hers, show no current price rather than an older one. When a program changes its price, the record, the pages that cite it and the changelog are updated together.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)